Yolken R - Search Results

1

Polymorphisms in human endogenous retrovirus K-18 and risk of type 2 diabetes in individuals with schizophrenia.

Dickerson F, Rubalcaba E, Viscidi R, Yang S, Stallings C, Sullens A, Origoni A, Leister F, Yolken R. Dickerson F, et al. Among authors: yolken r. Schizophr Res. 2008 Sep;104(1-3):121-6. doi: 10.1016/j.schres.2008.05.005. Epub 2008 Jul 10. Schizophr Res. 2008. PMID: 18617371

2

The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia.

Dickerson F, Boronow J, Stallings C, Origoni A, Yolken R. Dickerson F, et al. Among authors: yolken r. Schizophr Res. 2007 Jan;89(1-3):173-6. doi: 10.1016/j.schres.2006.08.015. Epub 2006 Oct 5. Schizophr Res. 2007. PMID: 17029750

3

Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality.

Dickerson F, Boronow J, Stallings C, Origoni A, Yolken R. Dickerson F, et al. Among authors: yolken r. Schizophr Bull. 2007 May;33(3):737-40. doi: 10.1093/schbul/sbm005. Epub 2007 Feb 20. Schizophr Bull. 2007. PMID: 17314085 Free PMC article.

4

C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia.

Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R. Dickerson F, et al. Among authors: yolken r. Schizophr Res. 2007 Jul;93(1-3):261-5. doi: 10.1016/j.schres.2007.03.022. Epub 2007 May 8. Schizophr Res. 2007. PMID: 17490859

5

Antibodies to measles in individuals with recent onset psychosis.

Dickerson F, Stallings C, Origoni A, Copp C, Khushalani S, Yolken R. Dickerson F, et al. Among authors: yolken r. Schizophr Res. 2010 Jun;119(1-3):89-94. doi: 10.1016/j.schres.2009.12.010. Epub 2010 Jan 3. Schizophr Res. 2010. PMID: 20051313

6

Artemisinin reduces the level of antibodies to gliadin in schizophrenia.

Dickerson F, Stallings C, Vaughan C, Origoni A, Goga J, Khushalani S, Yolken R. Dickerson F, et al. Among authors: yolken r. Schizophr Res. 2011 Jul;129(2-3):196-200. doi: 10.1016/j.schres.2011.04.010. Epub 2011 May 5. Schizophr Res. 2011. PMID: 21546216 Clinical Trial.

7

Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia.

Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R. Dickerson F, et al. Among authors: yolken r. Schizophr Res. 2012 Jan;134(1):83-8. doi: 10.1016/j.schres.2011.10.003. Epub 2011 Nov 1. Schizophr Res. 2012. PMID: 22048011

8

Antibodies to retroviruses in recent onset psychosis and multi-episode schizophrenia.

Dickerson F, Lillehoj E, Stallings C, Wiley M, Origoni A, Vaughan C, Khushalani S, Sabunciyan S, Yolken R. Dickerson F, et al. Among authors: yolken r. Schizophr Res. 2012 Jul;138(2-3):198-205. doi: 10.1016/j.schres.2012.03.037. Epub 2012 Apr 27. Schizophr Res. 2012. PMID: 22542615

9

C-reactive protein is elevated in schizophrenia.

Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yang S, Yolken R. Dickerson F, et al. Among authors: yolken r. Schizophr Res. 2013 Jan;143(1):198-202. doi: 10.1016/j.schres.2012.10.041. Epub 2012 Dec 4. Schizophr Res. 2013. PMID: 23218564

10

Mortality in schizophrenia: clinical and serological predictors.

Dickerson F, Stallings C, Origoni A, Schroeder J, Khushalani S, Yolken R. Dickerson F, et al. Among authors: yolken r. Schizophr Bull. 2014 Jul;40(4):796-803. doi: 10.1093/schbul/sbt113. Epub 2013 Aug 13. Schizophr Bull. 2014. PMID: 23943410 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

668 results

Search Page

Filters